ANTILYMPHOCYTE THERAPY IN KIDNEY TRANSPLANTATION: A PROSPECTIVE RANDOMIZED TRIAL OF FULL-DOSE RABBIT ANTI-HUMAN THYMOCYTE GLOBULIN (RATG) VERSUS LOW-DOSE RATG AND BASILIXIMAB

    loading  Checking for direct PDF access through Ovid

Excerpt

    loading  Loading Related Articles